T o protect against different types of infections, CD4
+ T cells differentiate into functionally distinct subsets that are characterized by the cytokines they produce. The differentiation process is controlled by regulatory proteins, of which GATA-3 is the factor that is both necessary and sufficient for Th2 differentiation (1) (2) (3) . GATA-3 acts as a lineage-specifying factor that is required for nervous system development, fetal liver hematopoiesis, and T cell development (4, 5) . GATA-3 expression is tightly regulated during development in different tissues, and small changes in the level of expression can have dramatic consequences. The most well-recognized level of GATA-3 regulation during Th2 differentiation is transcriptional regulation. GATA-3 expression is necessary for T cell development within the thymus, and GATA-3 mRNA levels are maintained at a low level in the periphery (5, 6) . Activation of STAT6 by IL-4 stimulation drives transcriptional upregulation of GATA-3 mRNA (7) . Additionally, the GATA-3 gene contains at least two promoters with different start sites of transcription, which allows for tissue-specific expression of GATA-3 (8) . Transcription of GATA-3 mRNA from the upstream exon 1A, which is primarily found in brain tissue, can be driven independently of IL-4 in T cells by Notch1 (9, 10) . In addition to the regulation of expression, three proteins restrict the functional capacity of GATA-3: friend of GATA-1, repressor of GATA, and T-bet (11) (12) (13) . An important function of GATA-3 is its ability to stabilize its own expression through transcriptional autoactivation (14) . The interplay between the positive-feedback loop and the negative regulators creates a threshold level of GATA-3 that must be reached for Th2 differentiation to occur. Thus, small changes in GATA-3 expression can have a dramatic impact on cell lineage commitment, as seen in humans with a genetic deficiency for GATA-3 at one allele, who suffer from hypoparathyroidism, sensorineural deafness, renal anomaly syndrome, and greatly reduced Th2 responses (15, 16) .
In addition to the effects of IL-4R and Notch1 signaling, TCR signaling has also been implicated in GATA-3 transcriptional regulation. Changing the affinity of the TCR for peptide MHC complexes using altered peptide ligands or changing the peptide dose impacts the GATA-3 mRNA level (17, 18) . Genetic disruption, or inhibition, of the downstream signaling molecules NF-kB and ERK also alters GATA-3 transcription (19, 20) . However, it has been difficult to elucidate specific effects of TCR signaling on GATA-3 expression and Th2 differentiation, because TCR signaling is required for initial T cell activation, survival, and expansion.
To bypass the requirement for TCR signaling in T cell expansion, we have used activated, undifferentiated T cells to determine specific contributions of IL-4R and TCR signaling toward GATA-3 expression and Th2 differentiation. We show in this study that expansion of activated, undifferentiated T cells is not dependent on Ag stimulation, but TCR signaling is absolutely required for Th2 differentiation. The impact of TCR signaling is not mediated through upregulation of GATA-3 transcription, as IL-4 induces GATA-3 mRNA equivalently in the presence or absence of Ag stimulation. Instead, TCR signaling is required to specifically increase the rate of GATA-3 translation, resulting in increased GATA-3 protein levels and subsequent Th2 differentiation.
Materials and Methods

T cell stimulation
CD4
+ T cells were purified by negative selection from DO11.10 TCR transgenic mice. All mouse experiments were approved by the University Committee on Animal Resources at the University of Rochester (Rochester, NY). Magnetic column separation was used to enrich for .90% CD62L hi cells. T cells were stimulated with 0.2 mM OVA peptide presented by irradiated BALB/c splenocytes plus 10 U/ml human IL-2 (hIL-2). For activated, undifferentiated T cells, 10 mg/ml anti-IL-4 was added to the cultures; for Th1 cells, 10 mg/ml anti-IL-4 and 10 ng/ml IL-12 was added; and for Th2 cells, 20 ng/ml IL-4 was added. Activated, undifferentiated cells were restimulated on day 5 with mitomycin C-treated 6132 Pro cell transfectants expressing class II (I-A d ) and B7-1 (ProAd-B7) (21) 6 2 mM OVA peptide and 6 20 ng/ml IL-4. A total of 10 U/ml hIL-2 was added to all restimulation cultures to provide for equivalent T cell expansion. Where indicated, cells were labeled with 1 mM CFSE at 37˚C for 5 min prior to restimulation. Where indicated, 10 mM LY294002 or 10 nM rapamycin was added during the restimulation. To assay for cytokine secretion, T cells were stimulated overnight with 1 mg/ml plate-bound anti-CD3 (2C11), and supernatants were assayed by capture ELISA for IL-2, IL-4, and IFN-g. For intracellular cytokine staining, brefeldin A was added 16-20 h poststimulation. Four hours later, cells were collected, fixed with paraformaldehyde, and permeabilized with 0.5% saponin. Cytokine staining was performed in 0.5% saponin with PE or allophycocyanin-labeled anti-IL-4 (BD Biosciences, San Jose, CA/eBioscience, San Diego, CA).
Real-time PCR
Total RNA was isolated from 10 6 T cells using TRIzol (Invitrogen, Carlsbad, CA), and cDNA was made with Superscript II Reverse Transcriptase (Invitrogen). The GATA-3 real-time PCR primers that spanned the exon 2-3 junction or the exon 4-5 junction and the CD3d and Lck primers were all obtained from Applied Biosystems (Carlsbad, CA). The custom exon 1a-and exon 1b-specific primers were also ordered from Applied Biosystems. The sequences for exon 1a primers are: forward 59-AG-CTGGCCTTCAGGAGAGA-39 and reverse 59-CGCTCAGAGACGGTT-GCT-39 with probe 59-CTTCCGATCACCAGGGCAG-39; and for exon 1b are: forward 59-GCCTCCTCCTCCTCCTCTAC-39 and reverse 59-CG-CTCAGAGACGGTTGCT-39 with probe 59-TTCCGATCACCTGAGTA-GCA-39. Plates were run on the 7900HT RT-PCR System (Applied Biosystems). GATA-3 level was normalized to CD3d (except where indicated) relative to activated, undifferentiated T cells prior to restimulation.
Protein analysis
Nuclear and cytosolic fractions were isolated from 3 3 10 6 T cells using NE-PER reagents (Pierce, Rockford, IL), and Western blots were probed with anti-GATA-3 mAb or anti-proliferating cell nuclear Ag (PCNA; Santa Cruz Biotechnology, Santa Cruz, CA). For all analyses, a 2-fold dilution curve of Th2 cell lysates was included on each blot and used to calculate fold differences between experimental samples. GATA-3 values were normalized to PCNA relative to activated, undifferentiated T cells prior to restimulation. For eukaryotic initiation factor (eIF) 2a experiments, cytosolic lysates were isolated using a Nonidet P-40 lysis buffer [1% Nonidet P-40, 50 mM Tris (pH 8), 150 mM NaCl, leupeptin, aprotinin, PMSF, and phosphatase inhibitor mixture I (Sigma-Aldrich, St. Louis, MO)] and probed with anti-phospho-eIF2 (Ser51), anti-eIF2a (Cell Signaling Technology, Danvers, MA), and anti-Lck (Santa Cruz Biotechnology). For biosynthetic labeling, T cells were pulse-labeled with 300 mCi/ml [ 35 S]trans label (PerkinElmer, Waltham, MA) and chased for various times with prewarmed complete media. Nuclear and cytosolic fractions were sequentially immunoprecipitated with GATA-3 and Lck Abs. The Western blot and autoradiograph analysis was done on the Fluor Chem 8900 (Alpha Innotech/Cell Biosciences, Santa Clara, CA). To determine the overall translational efficiency, the percent incorporation of [ 35 S]methionine/cysteine into newly synthesized proteins was determined following precipitation of the pulse-labeled proteins overnight at 220˚C with 100% ethanol.
Results
Th2 differentiation is specifically dependent on TCR signaling
To study the specific effects of IL-4R and TCR signaling on Th2 differentiation, we have generated activated, undifferentiated Th cells. Naive T cells from DO11.10 TCR transgenic mice are primed in the absence of polarizing cytokines and in the presence of anti-IL-4 to prevent Th2 differentiation. At day 5, these activated, undifferentiated cells make IL-2, but little to no IFN-g and IL-4 (Fig. 1A) . By comparison, cells stimulated in Th1 or Th2 conditions make high amounts of IFN-g and IL-4, respectively (Fig. 1A) . These activated, undifferentiated cells were then restimulated with IL-4, Ag, or Ag plus IL-4 for 6 d. The number of cells recovered at the end of the restimulation is similar in all stimulation conditions (Fig. 1B) . This indicates that TCR signaling of activated, undifferentiated cells is not required for T cell expansion. The ability of T cells to expand via cytokines allows us to determine if TCR signaling is specifically required for Th2 differentiation. Restimulation with either IL-4 or Ag on its own is not sufficient to induce Th2 differentiation, as measured by IL-4 ( Fig. 1C) and IL-5 (data not shown) production. Th2 differentiation only occurs poststimulation with both Ag and IL-4 (Fig. 1C) . To show that the dependence on TCR signaling for Th2 differentiation is not linked to cell division, we labeled activated, undifferentiated T cells with CFSE prior to restimulation. T cells efficiently enter the cell cycle under all stimulation conditions, although restimulation with IL-4 in the absence of Ag results in slightly delayed kinetics of CFSE dilution ( Fig. 2A) . Over time, T cells undergo similar rounds of cell division ( Fig. 2A ), corresponding to the equivalent level of T cell expansion (Fig. 1B) . However, little or no IL-4-producing cells are detected poststimulation with IL-4 or Ag alone (Fig. 2B ). Only cells that had been stimulated with Ag plus IL-4 are capable of producing IL-4 (Fig. 2B) . Thus, the defect in Th2 differentiation by cells stimulated with IL-4 or Ag is clearly not a secondary effect caused by a failure in cell division. Taken together, these data show that TCR signaling has a specific role in Th2 differentiation that is independent of the requirement for TCR signaling in T cell survival and expansion.
TCR signaling increases GATA-3 protein levels without affecting GATA-3 mRNA levels Previous reports have suggested that TCR signaling components may play a role in the transcriptional regulation of GATA-3 (17) (18) (19) (20) 22) . We measured the induction of GATA-3 mRNA to determine if TCR signaling enhances GATA-3 expression during the restimulation of activated, undifferentiated T cells. Notably, we find that IL-4 stimulation drives GATA-3 mRNA induction in the presence or absence of Ag stimulation (Fig. 3A) . TCR signaling is unable to drive GATA-3 mRNA on its own or, more importantly, amplify the level of GATA-3 mRNA when added to IL-4 stimulation (Fig. 3A) . We believe that this induction of mRNA is reflective of trans- criptional activation, as there is no change in GATA-3 mRNA stability in the presence or absence of Ag stimulation (data not shown). The relative amount of GATA-3 mRNA in cells primed under Th2 conditions during initial priming is similar to the level of IL-4-induced GATA-3 mRNA, whereas Th1 cells have greatly reduced GATA-3 mRNA (Fig. 3B) . Similar results were obtained for GATA-3 mRNA induction using primers that span both the exon 2-3 ( Fig. 3A, 3B ) and the exon 4-5 junctions (data not shown). GATA-3 transcripts can be initiated by two different promoters, resulting in mRNA molecules that differ only in the exon 1 portion of their 59 untranslated region (UTR) (8) . Transcription from the downstream promoter represents the majority of the overall GATA-3 mRNA level in resting T cells [data not shown (23)]. To determine if IL-4 signaling preferentially induces one of these promoters, we designed real-time PCR primers that span the exon 1A and exon 1B-2 junctions. We find that IL-4 stimulation induces GATA-3 mRNA from both the upstream and downstream promoters and that Ag stimulation does not have any impact on the mRNA level from either promoter, on its own or when added to IL-4 stimulation (Fig. 3C, 3D ). These data indicate that IL-4 stimulation is sufficient for GATA-3 mRNA induction in the absence of concomitant TCR signaling and that the TCR-driven increase in Th2 differentiation is not mediated by an increase in GATA-3 mRNA.
In contrast to the lack of any impact of TCR signaling on IL-4-induced GATA-3 mRNA, TCR signaling does increase GATA-3 protein levels. IL-4 stimulation induces a small increase in GATA-3 protein (Fig. 3E, 3F ). In contrast, the combination of Ag and IL-4 stimulation induces a greater level of GATA-3 protein than IL-4 stimulation, despite equivalent induction of GATA-3 mRNA (Fig. 3A, 3F ). The ability of TCR signaling to increase the level of GATA-3 protein without increasing the level of GATA-3 mRNA implicates a mechanism of TCR-dependent posttranscriptional control of GATA-3 expression.
GATA-3 translation rate is enhanced by Ag stimulation
To determine if the posttranscriptional increase is mediated by an increase in GATA-3 protein synthesis, we measured the rate of GATA-3 translation by pulse labeling with [ 35 S]methionine/ cysteine. A significant increase in the level of de novo synthesis of GATA-3 is detected in Ag plus IL-4-stimulated cells when compared with IL-4-stimulated cells (Fig. 4A) . The increase in Ag-stimulated cells is specific for GATA-3, as we detect similar levels of the control proteins Lck (Fig. 4A) and MHC class I (data not shown). Furthermore, the percent incorporation of [
35 S]methionine/cysteine into newly synthesized proteins is equivalent between IL-4-and Ag plus IL-4-stimulated cells, indicating that the overall translational efficiency is not increased by Ag stimulation (Fig. 4B) . To determine the GATA-3 translation rate, we measured the amount of protein produced during the pulse label (Fig. 4A) and divided by the amount of mRNA (Fig. 4C) , both relative to Lck. We see a consistent 4-fold increase in the GATA-3 translation rate in the presence of TCR signaling (Fig. 4D) . Thus, these data show that TCR signaling specifically increases the translation of GATA-3, resulting in higher GATA-3 protein levels and Th2 differentiation.
The priming of CD4 + T cells induces components of the integrated stress response, resulting in phosphorylation of eIF2a at Ser 51 (24) . This phosphorylation prevents exchange of GDP for GTP by eIF2B and renders initiation complexes ineffective, resulting in translational arrest of key proteins, including IL-4. Acute restimulation through the TCR relieves the stress response, resulting in dephosphorylation of eIF2a and an increase in global translational efficiency. To determine if the stress response is contributing to the TCR-dependent increase in GATA-3 translation, we measured the phosphorylation state of eIF2a at Ser 51 in activated, undifferentiated cells stimulated with IL-4, Ag, or Ag plus IL-4. At 48 h poststimulation, the time we detect an increase in the GATA-3 translation rate, there is no difference in the amount of eIF2a phosphorylation (Fig. 5A, 5C) . As a control, we measured induction of eIF2a phosphorylation in fibroblast cells treated with tunicamycin, a potent inducer of the stress response, which results in a 5-fold increase in phosphorylation (Fig. 5B, 5D ). Taken together, these data further show that the TCR-dependent translational increase is specific for GATA-3 and not due to a global enhancement of translation.
TCR signaling does not enhance GATA-3 protein stability
It has been shown that signaling through ERK can increase GATA-3 protein stability (25) . To determine if an additional TCRmediated effect on GATA-3 protein stability also contributes to the posttranscriptional increase in GATA-3 protein, we calculated the GATA-3 protein t 1/2 with a pulse-chase assay (Fig. 6A, 6B) . The number of IL-4-stimulated cells was adjusted during the pulse label to compensate for the decreased GATA-3 translation in the absence of TCR signaling, so the IL-4-and Ag plus IL-4-stimulated samples have similar starting levels of GATA-3. We find that the degradation of biosynthetically labeled GATA-3 protein is not affected by Ag stimulation (Fig. 6A, 6B ). This result is confirmed when GATA-3 protein stability is measured after blocking new protein synthesis with cycloheximide (Fig. 6C, 6D ). GATA-3 has a similar rate of degradation in cells stimulated with IL-4 in the presence or absence of TCR signaling. Thus, the S]methionine/cysteine for 10 min, then chased with unlabeled media for various times. Nuclear and cytosolic lysates were immunoprecipitated for GATA-3 and Lck and analyzed on SDS gels. The cell number was adjusted so that the IL-4 and Ag + IL-4 samples have similar starting levels of GATA-3 protein to account for the Ag-driven increase in GATA-3 translation. A, One gel, representative of three, is shown. B, The quantitation of GATA-3 protein level during the pulse chase experiments is depicted as mean 6 SD; n = 3. For some experiments, the pulse time was increased to 60 min. C and D, A total of 100 mg/ml CHX was added to T cells, and protein levels of GATA-3 and PCNA were measured by Western blot of nuclear lysates. C, One Western blot, representative of three, is shown. D, The quantitation of GATA-3 protein level postaddition of CHX is depicted as mean 6 SEM; n = 3. CHX, cycloheximide.
posttranscriptional increase in GATA-3 protein in Ag-stimulated cells is a direct effect of an increased GATA-3 translation rate and not due to an increase in GATA-3 protein stability.
PI3K signaling through mammalian target of rapamycin is required for enhanced GATA-3 translation and Th2 differentiation
The PI3K-mediated conversion of phosphatidylinositol 4,5-bisphosphate to phosphatidylinositol 3,4,5-trisphosphate serves as a membrane-recruitment site for pleckstrin homology domaincontaining proteins including Akt, PDK1, Itk, and Vav (26) . Signaling through Akt leads to activation of the mammalian target of rapamycin (mTOR) kinase, a protein central to cell growth and the regulation of both gene-specific and global translation. To determine if the PI3K-mTOR pathway is involved in GATA-3 translation, we measured GATA-3 mRNA and protein levels in the absence of PI3K signaling. Inhibition of PI3K with the inhibitor LY294002 has no effect on GATA-3 mRNA levels, but specifically decreases the level of GATA-3 protein (Fig. 7A-C) . These data suggest that PI3K signaling is required for the TCR-dependent increase in GATA-3 translation. To determine whether the decrease in GATA-3 protein is due to a specific translational defect or reflective of a global effect of PI3K, we measured de novo protein synthesis by [ 35 S]methionine/cysteine pulse labeling. Consistent with the role of PI3K signaling in global translational efficiency, there is a slight decrease in the overall translation rate in the presence of the PI3K inhibitor (Fig. 7D) . However, in addition to this global effect, there is a specific decrease in GATA-3 translation (Fig. 7E, 7F ). The reduction in GATA-3 translation is greater than the reduction in global translation, and when GATA-3 is normalized, for both mRNA and protein, to Lck, we detect a specific decrease in the GATA-3 translation rate (Fig. 7E, 7F) . Thus, the addition of LY294002 specifically decreases the GATA-3 translation rate, indicating that the TCR-dependent specific increase in GATA-3 translation is mediated by signaling through PI3K. To determine if this pathway is dependent on mTOR, T cells were treated with rapamycin. Addition of rapamycin to Ag plus IL-4-stimulated cells does not affect the level of GATA-3 mRNA (Fig.  7G) . Rather, the level of GATA-3 protein is decreased in the absence of mTOR signaling (Fig. 7H, 7I ), indicating that mTOR signaling is required for the TCR-mediated translational upregulation of GATA-3. Taken together, these data indicate that the TCRmediated induction of GATA-3 translation is dependent on PI3K signaling through mTOR.
The induction of Th2 responses in vivo has been shown to be dependent on PI3K signaling. However, these effects may be T cell independent, as alteration of PI3K signaling has effects on dendritic cell IL-12 production, mast cell and eosinophil recruitment, and airway hyperresponsiveness in asthma models (27) (28) (29) (30) . In vitro, the effect of PI3K inhibition on Th2 differentiation is concomitant with a decrease in cell division, making it unclear if the effect is specific for the Th2 program or a secondary consequence of the block in T cell expansion (31) . Consistent with this, we detect major decreases in cell expansion poststimulation of naive T cells in the presence of LY294002 or rapamycin (data not shown). However, using activated, undifferentiated T cells allows us to measure Th2 differentiation while bypassing this effect of PI3K inhibition on cell expansion. Although there is a slight decrease in cell division, addition of LY294002 or rapamycin has no effect on T cell expansion of previously activated cells (Fig. 8A, 8C) . In contrast to the minimal FIGURE 7. PI3K signaling through mTOR is required for enhanced GATA-3 translation. Activated, undifferentiated T cells were restimulated with both IL-4 and OVA peptide presented by ProAd-B7 cells in the presence of 10mM LY294002 (LY294), 10 nM Rap, or vehicle control DMSO; hIL-2 was added to all stimulation conditions. A, GATA-3 mRNA was measured by real-time PCR at different times following restimulation. The fold induction of GATA-3 mRNA, relative to activated, undifferentiated cells, is depicted as mean 6 SEM; n $ 5 for each time point. B, GATA-3 protein was measured 48 h postrestimulation by Western blot of nuclear lysates. C, The amount of GATA-3 protein relative to unstimulated cells is depicted as mean + SEM. p = 0.0018 for DMSO-versus LY294-treated samples by paired t test; n = 4. D and E, Forty-eight hours postrestimulation, T cells were pulsed with [ ]methionine/cysteine into ethanol-precipitable proteins from the pulse-labeled lysates. Data are depicted as mean + SEM; n = 2. E, Nuclear and cytosolic lysates were immmunoprecipitated for GATA-3 and Lck and analyzed on SDS gels. F, The GATA-3 translation rate was calculated as the amount of detectable radioactivity from the pulse period divided by the amount of mRNA at the time of the pulse label, both normalized to Lck. Data are depicted as mean + SEM; n = 2. G, GATA-3 mRNA was measured as in A and is depicted as mean 6 SEM; n = 3. H and I, GATA-3 protein was measured as in B and is depicted as mean + SEM. p = 0.0041 for DMSO-versus Rap-treated samples by paired t test; n = 5. Rap, rapamycin.
The Journal of Immunologyeffects on cell expansion, the amount of Th2 differentiation is greatly reduced with LY294002 or rapamycin treatment (Fig. 8B,  8C ). These data indicate that there is a specific defect in Th2 differentiation in the absence of PI3K/mTOR signaling and that this defect correlates with a failure to upregulate GATA-3 translation.
Discussion
The transcription factor GATA-3 is a tightly regulated protein that is essential for Th2 responses (1). To understand the signaling pathways that lead to GATA-3 upregulation, we have developed stimulation conditions that allow us to separately study the contributions of IL-4R and TCR signaling. We have identified a role of TCR signaling in GATA-3 translation that is independent of the role of TCR signaling in initial T cell activation, survival, and expansion. This translational increase is specific for GATA-3 and responsible for the TCR-dependent increase in GATA-3 protein that is associated with increased Th2 differentiation.
The majority of data investigating GATA-3 expression has focused on transcriptional upregulation. It was initially shown that addition of IL-4 to activated T cells promotes Th2 differentiation and GATA-3 transcription through the activation of the transcription factor STAT6 (7, 32, 33) . Although the role of STAT6 in promoting GATA-3 transcription is well established, the previous experiments have been done in the presence of concomitant TCR signaling, making it difficult to determine if STAT6 is working independently or in concert with molecules downstream of the TCR. A role for TCR signaling in regulating GATA-3 induction and subsequent Th2 differentiation was first implicated by altering TCR signaling through the use of altered peptide ligands or changing the Ag dose (17, 18) . Additionally, T cells from p50-or Bcl-3-deficient mice have a defect in GATA-3 induction and Th2 differentiation in the presence of exogenous IL-4, suggesting a role for NF-kB signaling in conjunction with STAT6 for GATA-3 upregulation (19, 34) . However, the NF-kB pathway is activated downstream of many different receptors, and genetic disruption of this pathway results in developmental defects both within and outside the T cell compartment. Furthermore, inhibition of TCR signaling using knockout animals or by altering the peptide dose or affinity may simply reduce the early TCR-dependent production of IL-4 rather than directly affect GATA-3 induction. It was recently shown that TCR activation can induce GATA-3 mRNA in the absence of IL-4 through the transcription factor T cell-specific factor-1 (22) . Although our data in both naive (data not shown) and previously activated cells, as well as previous reports, have shown a dependence on IL-4 and STAT6, this recent finding suggests that under some conditions, signaling through the TCR may be sufficient to induce GATA-3 mRNA upregulation. Thus, TCR signaling can impact GATA-3 mRNA upregulation in multiple ways: direct induction independent of STAT6, in conjunction with IL-4R signaling, or indirectly through induction of IL-4. We have designed our experiments to restrict the effects of TCR signaling to modulation of Th2 differentiation, and under these conditions, we find that TCR signaling does not have any impact on GATA-3 mRNA upregulation. Despite the many ways in which TCR signaling can potentially impact GATA-3 mRNA, these results highlight that none of these pathways are required, as IL-4 is capable of driving GATA-3 mRNA independently of Ag stimulation. Although we cannot rule out any long-lasting effect of the initial stimulation, we show that in the absence of acute TCR stimulation, IL-4 stimulation is sufficient to drive GATA-3 mRNA induction and that addition of TCR signaling does not increase the level of IL-4-driven GATA-3 mRNA.
Priming of naive CD4 + T cells both in vivo and in vitro can lead to proliferating cells that produce IL-2, but neither IL-4 nor IFN-g (35, 36) . These cells maintain a flexible differentiation state and can be pushed into different subsets depending on the nature of the secondary challenge. This flexibility could be compromised if exposure to polarizing cytokines in the absence of cognate Ag resulted in GATA-3 protein upregulation. Our data establish a clear requirement for concomitant TCR and IL-4R signaling to direct Th2 responses for primed, undifferentiated T cells, with IL-4R signaling important for upregulation of GATA-3 mRNA and TCR signaling for enhancement of GATA-3 translation. This establishes the translational control of GATA-3 as a key point of signal integration associated with Th2 differentiation, providing a layer of protection against aberrant GATA-3 production, which could lead to Th2-biased immune responses and atopic diseases, such as asthma.
In addition to the signaling pathways that modulate transcriptional activation of GATA-3, it has been reported that ERK signaling can modulate GATA-3 protein stability (25) . Targeted deletion of growth factor independent-1, for which induction is reduced by inhibition of ERK, results in decreased stability of GATA-3 protein and subsequent Th2 differentiation (37) . However, we find that Ag stimulation has no effect on GATA-3 protein stability. Furthermore, inhibition of ERK activation did not alter the level of TCR-induced GATA-3 protein (data not shown). Although it remains possible that under some stimulation conditions TCR signaling may contribute to GATA-3 stability through ERK activation, this mechanism is not required for TCR signaling to enhance GATA-3 protein levels. The more significant contribution of TCR signaling toward GATA-3 protein levels is through the enhancement of the GATA-3 translation rate.
Translational control of gene expression can be mediated through effects on the global translational machinery or through gene-specific effects. TCR signaling has been shown to impact global translational efficiency following initial T cell activation through effects on the expression level and functional activity of translation initiation factors (24, 38, 39) . Specifically, the dephosphorylation of eIF2a following acute TCR stimulation has been shown to enhance translational activity (24) . The ability of TCR signaling to promote dephosphorylation of eIF2a is likely a timerestricted event that is dependent on the strength of the signaling. Accordingly, we find that there is no change in the phosphorylation state of eIF2a in the presence or absence of Ag stimulation at the time we detect an increase in the GATA-3 translation rate. Rather, we find that Ag stimulation specifically induces translation of GATA-3 without affecting phosphorylation of eIF2a, global translational efficiency, or the translation of control proteins.
In addition to the effects on eIF2a, TCR signaling can also impact both global and gene-specific translation through PI3K and mTOR. The best-characterized mechanism of mTOR-dependent control of translation is through phosphorylation of eIF4E-BP, an inhibitor of ribosome recruitment to the 59 end of an mRNA molecule (40) . This phosphorylation decreases affinity of eIF4E-BP for eIF4E, allowing eIF4G to bind eIF4E and recruit the ribosome to initiate translation. This process appears to be more complex than initially suggested, however, as overexpression of eIF4E selectively enhances translation of mRNA molecules that contain secondary structures within their 59 UTR (41) . GATA-3 transcripts contain unusually long 59 UTRs, which contain many potential structural elements. The PI3K pathway effect on eIF4E-BP phosphorylation may have a larger effect on these structured 59 UTRcontaining mRNA molecules, including GATA-3. An additional step necessary only for translation of mRNA with structured 59 UTR is the eIF4A helicase-dependent unwinding of mRNA (42) . The activity of eIF4A can be regulated by the PI3K-mTOR pathway through the phosphorylation-dependent binding of eIF4B to eIF4A (43) . Reduction of this phosphorylation through PI3K inhibition could lead to decreased translation of GATA-3 and other mRNAs with structured 59 UTR. Global translation is also enhanced by PI3K/mTOR signaling through enhanced generation of ribosome components. This enhanced translation is dependent on mTOR and the presence of a 59 terminal oligopyrimidine tract, a polypyrimidine stretch adjacent to the 59 end of mRNA molecule (44) . Interestingly, GATA-3 mRNA molecules contain multiple polypyrimidine stretches within their 59 UTR. Although these elements are not in the correct position to be classified as a terminal oligopyrimidine, these regions could confer mTOR-dependent translational control.
Further experiments are needed to determine if these potential mechanisms are responsible for the TCR-mediated enhancement of GATA-3 translation. Understanding how the different transcriptional and posttranscriptional regulatory elements cooperate to mediate the fine control of GATA-3 expression will be key to understanding how this pathway may be misregulated in atopic diseases or can be targeted for immune manipulation.
